Search results for "g COVID-19"

showing 4 items of 4 documents

Interventions for Improving Long COVID-19 Symptomatology: A Systematic Review

2022

Introduction: Although the understanding of several aspects of long COVID-19 syndrome is increasing, there is limited literature regarding the treatment of these signs and symptoms. The aim of our systematic review was to understand which therapies have proved effective against the symptoms of long COVID-19. Methods: A systematic search for randomized controlled or clinical trials in several databases was conducted through 15 May 2022. Specific inclusion criteria included: (1) intervention studies, either randomized controlled (RCTs) or clinical trials; (2) diagnosis of long COVID-19, according to the World Health Organization criteria; (3) presence of long COVID-19 for at least 12 weeks af…

AdultPost-Acute COVID-19 SyndromeInfectious DiseasesSARS-CoV-2VirologyCOVID-19 SARS-CoV-2 interventions long COVID-19 therapyCOVID-19HumansFemaleLuteolinViruses
researchProduct

Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study

2022

Background and ObjectivesSeveral studies have assessed risk factors associated with the severity of COVID-19 outcomes in people with multiple sclerosis (PwMS). The potential role of disease-modifying therapies (DMTs) and demographic and clinical factors on the risk of acquiring SARS-CoV-2 infection has not been evaluated so far. The objective of this study was to assess risk factors of contracting SARS-CoV-2 infection in PwMS by using data collected in the Italian MS Register (IMSR).MethodsA case-control (1:2) study was set up. Cases included PwMS with a confirmed diagnosis of COVID-19, and controls included PwMS without a confirmed diagnosis of COVID-19. Both groups were propensity score–m…

AdultMaleMultiple SclerosisTime Factors41Dimethyl FumarateSex FactorRelapsing-RemittingSeverity of Illness IndexArticleImmunosuppressive AgentSex FactorsMultiple Sclerosis Relapsing-RemittingRisk FactorsMultiple SclerosiOdds RatioHumansAge Factor36053g COVID-19Fingolimod HydrochlorideSARS-CoV-2NatalizumabRisk FactorAge FactorsCOVID-19Glatiramer AcetateInterferon-betaMiddle AgedMultiple Sclerosis Chronic Progressive323Chronic ProgressiveNeurologyItalyCase-Control StudiesAdult; Age Factors; COVID-19; Case-Control Studies; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Italy; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis Chronic Progressive; Multiple Sclerosis Relapsing-Remitting; Natalizumab; Odds Ratio; Risk Factors; SARS-CoV-2; Severity of Illness Index; Sex Factors; Time FactorsFemaleNeurology (clinical)Case-Control StudieImmunosuppressive AgentsHuman
researchProduct

Going through the lockdown: a longitudinal study on the psychological consequences of the coronavirus pandemic

2021

Coronavirus 2019 pandemic lockdown in Italy lasted for 2 months, 1 week and 2 days. During this long period, one of the longest in Europe, the restrictions produced effects on people’s psychological well-being, with consequences that also continued after lockdown. The purpose of the study is to investigate these effects and how they changed in the general population over a period of time. We are also interested in exploring people’s post-lockdown anxiety and concerns. We conducted an online survey using snowball sampling techniques. The longitudinal study consisted of four administrations covering a period of 10 weeks between April (baseline) and June (last follow-up). Levels of anxiety and…

negative emotions COVID-19 relatedCoping (psychology)Longitudinal studylcsh:BF1-990PopulationPsychological intervention03 medical and health sciencesSocial support0302 clinical medicinemedicine030212 general & internal medicineeducationeducation.field_of_studySpecial section COVID-19Mental healthCoronavirusPsychiatry and Mental healthClinical Psychologyanxiety COVID-19 relatedlcsh:PsychologySnowball samplingdepression COVID-19 relatedCOVID-19 longitudinal studynegative emotions COVID-19 related.Anxietymedicine.symptomPsychologysocial support during COVID-19030217 neurology & neurosurgeryClinical psychologyResearch in Psychotherapy: Psychopathology, Process and Outcome
researchProduct

Risk of Contracting COVID-19, Personal Resources and Subjective Well-Being among Healthcare Workers: The Mediating Role of Stress and Meaning-Making

2021

The latest research suggests that the relationships between the risk of contracting COVID-19, personal resources and subjective well-being have rather an indirect character and can include the occurrence of mediating factors related to meaning-making processes and stress experiences. Protection motivation theory offers a theoretical paradigm that enables these associations to be thoroughly investigated and understood. The current study aimed to examine the mediating roles of meaning-making and stress in the relationship of risk of contracting COVID-19 and personal resources (self-efficacy and meaning in life) with subjective well-being among healthcare workers. A total of 225 healthcare wor…

Stress managementrisk of contracting COVID-19; personal resources; meaning-making; stress; subjective well-being; healthcare workersrisk of contracting COVID-19lcsh:MedicineArticleDevelopmental psychology03 medical and health sciencesstress0302 clinical medicineHealth careStress (linguistics)Meaning-makingMedicine030212 general & internal medicineMeaning (existential)Subjective well-beingpersonal resourcesSet (psychology)business.industryhealthcare workerslcsh:RCognitionGeneral Medicinemeaning-making030227 psychiatrysubjective well-beingbusinessJournal of Clinical Medicine
researchProduct